Corrigendum to Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia. [British Journal of Haematology (2014) 167, 376-384] doi: 10.1111/bjh.13054;Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia

British Journal of Haematology

Volumn 167, Issue 3, 2014, Pages 376-384

  Mak, Po Y ^a   Mak, Duncan H ^a   Ruvolo, Vivian ^a   Jacamo, Rodrigo ^a   Kornblau, Steven M ^a   Kantarjian, Hagop ^a   Andreeff, Michael ^a   Carter, Bing Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute myeloid leukaemia; Apoptosis repressor with caspase; BIRC2; Birinapant; MAP3K14

Indexed keywords

APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; BIRINAPANT; INHIBITOR OF APOPTOSIS PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 14; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; APOPTOSIS REGULATORY PROTEIN; BIRC2 PROTEIN, HUMAN; DIABLO PROTEIN, HUMAN; DIPEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; INHIBITOR OF APOPTOSIS PROTEIN; MITOCHONDRIAL PROTEIN; MUSCLE PROTEIN; NF-KAPPA B KINASE; NOL3 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; AGED; ANTAGONISTS AND INHIBITORS; BLOOD; COCULTURE; DRUG DESIGN; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; COCULTURE TECHNIQUES; DIPEPTIDES; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INDOLES; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MOLECULAR TARGETED THERAPY; MUSCLE PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84912046431     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13774     Document Type: Erratum

References (30)

1. Benito, J., Shi, Y., Szymanska, B., Carol, H., Boehm, I., Lu, H., Konoplev, S., Fang, W., Zweidler-McKay, P.A., Campana, D., Borthakur, G., Bueso-Ramos, C., Shpall, E., Thomas, D.A., Jordan, C.T., Kantarjian, H., Wilson, W.R., Lock, R., Andreeff, M. & Konopleva, M. (2011) Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS ONE, 6, e23108.
2. Carter, B.Z., Milella, M., Tsao, T., McQueen, T., Schober, W.D., Hu, W., Dean, N.M., Steelman, L., McCubrey, J.A. & Andreeff, M. (2003a) Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia, 17, 2081-2089.
3. Carter, B.Z., Wang, R.Y., Schober, W.D., Milella, M., Chism, D. & Andreeff, M. (2003b) Targeting survivin expression induces cell proliferation defect and subsequent cell death involving the mitochondrial pathway in myeloid leukemic cell. Cell Cycle, 2, 488-493.
4. Carter, B.Z., Gronda, M., Wang, Z., Welsh, K., Pinilla, C., Andreeff, M., Schober, W.D., Nefzi, A., Houghten, R.A., Brandwein, J., Minden, M.D., Schuh, A., Wells, R.A., Chun, K., Reed, J.C. & Schimmer, A.D. (2005) Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood, 105, 4043-4050.
5. Carter, B.Z., Mak, D., Schober, W.D., Cabreira-Hansen, M., Beran, M., McQueen, T., Chen, W. & Andreeff, M. (2006a) Regulation of survivin expression through bcr-abl/MAPK cascade: targeting survivin overcomes Imatinib resistance and increases Imatinib sensitivity in Imatinib responsive CML cells. Blood, 107, 1555-1563.
6. Carter, B.Z., Mak, D.H., Shi, Y., Schober, W.D., Wang, R.Y., Konopleva, M., Koller, E., Dean, N.M. & Andreeff, M. (2006b) Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistance. Cell Cycle, 5, 2223-2229.
7. Carter, B.Z., Mak, D.H., Schober, W.D., Koller, E., Pinilla, C., Vassilev, L.T., Reed, J.C. & Andreeff, M. (2010) Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML. Blood, 115, 306-314.
8. Carter, B.Z., Mak, D.H., Morris, S.J., Borthakur, G., Estey, E., Byrd, A.L., Konopleva, M., Kantarjian, H. & Andreeff, M. (2011a) XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34 + 38- cells in a phase 1/2 study of patients with relapsed/refractory AML. Apoptosis, 16, 67-74.
9. Carter, B.Z., Mak, D.H., Qiu, Y., Kornblau, S., Mak, P.Y., Weng, D., McKinlay, M.A. & Andreeff, M. (2011b) Antagonizing IAPs by SMAC mimetic TL32711 induces apoptosis in AML cells including AML stem/progenitor cells alone and in combination with chemotherapy. Blood, 118, 32a.
10. Carter, B.Z., Qiu, Y.H., Zhang, N., Coombes, K.R., Mak, D.H., Thomas, D.A., Ravandi, F., Kantarjian, H.M., Koller, E., Andreeff, M. & Kornblau, S.M. (2011c) Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML. Blood, 117, 780-787.
11. Carter, B.Z., Qiu, Y., Huang, X., Diao, L., Zhang, N., Coombes, K.R., Mak, D.H., Konopleva, M., Cortes, J., Kantarjian, H.M., Mills, G.B., Andreeff, M. & Kornblau, S.M. (2012) Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood, 120, 173-180.
12. Carter, B.Z., Mak, P.Y., Mak, D.H., Shi, Y., Qiu, Y., Bogenberger, J.M., Mu, H., Tibes, R., Yao, H., Coombes, K.R., Jacamo, R.O., McQueen, T., Kornblau, S.M. & Andreeff, M. (2014) Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents. Journal of the National Cancer Institute, 106, In press.
13. Cheung, H.H., St Jean, M., Beug, S.T., Lejmi-Mrad, R., LaCasse, E., Baird, S.D., Stojdl, D.F., Screaton, R.A. & Korneluk, R.G. (2011) SMG1 and NIK regulate apoptosis induced by Smac mimetic compounds. Cell Death & Disease, 2, e146.
14. Chou, T.C. & Talalay, P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55.
15. Du, C., Fang, M., Li, Y., Li, L. & Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33-42.
16. Foo, R.S., Chan, L.K., Kitsis, R.N. & Bennett, M.R. (2007) Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2. Journal of Biological Chemistry, 282, 5529-5535.
17. Gyurkocza, B., Plescia, J., Raskett, C.M., Garlick, D.S., Lowry, P.A., Carter, B.Z., Andreeff, M., Meli, M., Colombo, G. & Altieri, D.C. (2006) Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors. Journal of the National Cancer Institute, 98, 1068-1077.
18. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L.E. & Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature, 388, 190-195.
19. Konopleva, M.Y. & Jordan, C.T. (2011) Leukemia stem cells and microenvironment: biology and therapeutic targeting. Journal of Clinical Oncology, 29, 591-599.
20. Kornblau, S.M., Tibes, R., Qiu, Y.H., Chen, W.J., Kantarjian, H.M., Andreeff, M., Coombes, K.R. & Mills, G.B. (2009) Functional proteomic profiling of AML predicts response and survival. Blood, 113, 154-164.
21. Koseki, T., Inohara, N., Chen, S. & Nunez, G. (1998) ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proceedings of the National Academy of Sciences of the United States of America, 95, 5156-5160.
22. Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods, 25, 402-408.
23. Mak, P.Y., Mak, D.H., Mu, H., Shi, Y., Ruvolo, P., Ruvolo, V., Jacamo, R., Burks, J.K., Wei, W., Huang, X., Kornblau, S.M., Andreeff, M. & Carter, B.Z. (2014) Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML. Apoptosis, 19, 698-707.
24. Martin, S., Reutelingsperger, C., McGahon, A., Rader, J., van Schie, R., LaFace, D. & Green, D. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and ABL. Journal of Experimental Medicine, 182, 1545-1556.
25. Nam, Y.J., Mani, K., Ashton, A.W., Peng, C.F., Krishnamurthy, B., Hayakawa, Y., Lee, P., Korsmeyer, S.J. & Kitsis, R.N. (2004) Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Molecular Cell, 15, 901-912.
26. Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S.J., Krammer, P.H. & Peter, M.E. (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. Journal of Biological Chemistry, 274, 22532-22538.
27. Studeny, M., Marini, F.C., Champlin, R.E., Zompetta, C., Fidler, I.J. & Andreeff, M. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Research, 62, 3603-3608.
28. Tibes, R., Qiu, Y., Lu, Y., Hennessy, B., Andreeff, M., Mills, G.B. & Kornblau, S.M. (2006) Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Molecular Cancer Therapeutics, 5, 2512-2521.
29. Varfolomeev, E., Blankenship, J.W., Wayson, S.M., Fedorova, A.V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J.N., Elliott, L.O., Wallweber, H.J., Flygare, J.A., Fairbrother, W.J., Deshayes, K., Dixit, V.M. & Vucic, D. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell, 131, 669-681.
30. Vince, J.E., Wong, W.W., Khan, N., Feltham, R., Chau, D., Ahmed, A.U., Benetatos, C.A., Chunduru, S.K., Condon, S.M., McKinlay, M., Brink, R., Leverkus, M., Tergaonkar, V., Schneider, P., Callus, B.A., Koentgen, F., Vaux, D.L. & Silke, J. (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell, 131, 682-693.